Japan: innovation, excellence & partnership – a fireside chat with the JBA
30 Sep 2020
10:00 am - 10:45 am
MedCity is delighted to welcome partners from the Japan Bioindustry Association for a fireside chat on the evolution of the Japanese pharma and life sciences sector and opportunities for UK collaboration ahead of BIOJAPAN 2020
Following the new draft UK trade agreement with Japan and ahead of the forthcoming BioJapan conference, MedCity is delighted to host an informal fireside chat with our partners the Japan Bioindustry Association.
Speaking, will be Yoshiaki Tsukamoto, the Executive Director of the JBA and former professor of Tokyo Technical Institute and a globally recognised leader in Japanese Life Sciences organisation. Alongside will be Setsuo Morishita the Director of Business Development for the JBA.
Discussions will cover the evolution of the Japanese pharma and life sciences sector, new trends and approaches for UK science and collaboration in on of the largest pharma markets in the world. With the upcoming BioJapan annual conference taking place from 14-16 October this is a great opportunity to find out more about the benefits of collaboration with Japan and how partnering at this event could help forge those important partnerships.
MedCity is proud to be a partner of the JBA, the oldest and largest bioscience organisation in Japan with over 200 members. The annual BioJapan conference is one of the largest Bio Conferences in Asia. If you are interested in collaboration with Japan and want to find out more about potential market opportunities and benefits of partnering at Bio Japan – Register Here to join our short virtual event and take the opportunity to ask your questions to their leadership team